We isolated highly pure LSC-enriched and HSC fractions from CML-CP patients at diagnosis or from HD, based on a combination of cell surface markers (CD34, CD38, CD45, CD26) and flow cytometry parameters (FSC, SSC) (Supplementary Figure S1). The gene discussed is PTPRC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.